Mivacron In Dextrose 5% In Plastic Container

(mivacurium chloride)

PreclinicalSmall molecule

AbbVie

Indications

Total Trials

Active Trials

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Muscle RelaxantNot yet recruiting

Muscle RelaxantPreclinical

Not yet recruiting

Clinical

Trials by Indication[1]

Cirrhosis1 trial

Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis

Unknown status·TTang-Du Hospital·Phase 2·NCT02473601·80 enrolled

Effectiveness1 trial

Evaluation of Effectiveness of Two Different Doses of Mivacurium in Rapid Sequence Intubation

Unknown status·—·N/A·NCT06072534·100 enrolled

Muscle Relaxation1 trial

A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients

Completed·JJiangsu Nhwa Pharmaceutical Co., Ltd.·Phase 4·NCT02117401·1,152 enrolled

Muscle Relaxant1 trial

Muscle Relaxant Effect and Safety of Mivacurium Chloride and Succinylcholine for Bronchoscopy

Not yet recruiting·PPeng Liang·N/A·NCT06709066·240 enrolled

Regulatory

FDA Approval Timeline[4]

Jan 22, 1992

MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER

NDA NDA020098

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for mivacurium chloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — mivacurium chloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for mivacurium chloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA020098). U.S. Food & Drug Administration.
[5]
SEC EDGAR — AbbVie company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AbbVie